Compare DexCom, Inc. (DXCM) vs First Trust NASDAQ Clean Edge Green Energy Idx Fd (QCLN) Price & Performance

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

The First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN) is trading at $51.65, down 5.92% in the last 24 hours, with a bearish technical signal. The ETF's technical indicators show oversold conditions on short-term RSI, but moving averages signal continued downward pressure. Recent news highlights significant growth in clean energy demand from data centers and international investment, though regulatory hurdles in the U.S. and supply chain costs present headwinds.

The outlook for QCLN is mixed, balancing strong sectoral tailwinds against near-term technical weakness and policy uncertainty. Investment opportunity lies in the structural growth of low-emission power, which is outpacing global electricity supply. Key risks include U.S. permitting delays impacting over $121 billion in projects, geopolitical tensions affecting supply chains, and potential volatility from shifting regulatory landscapes.